脑利钠肽与急性冠脉综合征主要不良事件的关系(3)
[4] Braunwald E,Antman EM,Beasley JW. et al. ACC/AHA2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction summary article:a report of the American College of Cardiology/American Heart Association taskforce on practice guidelines[J]. Am Coll Cardiol,2002,40(7):1366- 1374.
[5] 吴士礼. 脑钠肽的生物学特性及其在急性冠脉综合征中的临床应用进展[J]. 中国心血管病研究,2005,3:545-546.
[6] 杨曙光. 脑钠肽在心力衰竭诊断、预后判定及治疗中应用的研究进展[J]. 现代诊断与治疗,2004,15(2):68-72.
[7] Hama N,Itoh H,Shirakami G,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction[J]. Circulation,1995,92(6):1558-1563.
[8] Goetze JP,Christoffersen C,Perko M,et al. necreased cardiac BNP expression associated with myocardial ischemia[J]. FASEB J,2003,17(9):1105-1107.
[9] Asada J, Tsuji H, Iwasaka T, et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia[J]. Am J Cardiol,2004,93(6):702-704.
[10] 季柏林. 血浆脑钠素水平与急性冠状动脉综合症病变程度的关系[J]. 浙江医学,2008,30(6):648-649.
[11] 刘树英. 脑利钠肽在ST段抬高型急性心肌梗死溶栓治疗患者的预测价值[J]. World Health Digest,2007,4(9):59-60.
[12] Morita E,Yoshimura M. Increased plasma levels of brain natriuretic peptide in patientswithacute myocardial infarction[J]. Circulation,1993,88:82-91.
[13] 曹雅旻,胡大一,闫丽. 急性冠脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J]. 中华心血管病杂志,2005,10(10):899-902.
[14] Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction[J]. Heart,1999,81:114-120.
(收稿日期:2009-03-05), 百拇医药(纪 军 何胜虎 陈 述 谢 勇 刘晓东 徐日新)
[5] 吴士礼. 脑钠肽的生物学特性及其在急性冠脉综合征中的临床应用进展[J]. 中国心血管病研究,2005,3:545-546.
[6] 杨曙光. 脑钠肽在心力衰竭诊断、预后判定及治疗中应用的研究进展[J]. 现代诊断与治疗,2004,15(2):68-72.
[7] Hama N,Itoh H,Shirakami G,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction[J]. Circulation,1995,92(6):1558-1563.
[8] Goetze JP,Christoffersen C,Perko M,et al. necreased cardiac BNP expression associated with myocardial ischemia[J]. FASEB J,2003,17(9):1105-1107.
[9] Asada J, Tsuji H, Iwasaka T, et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia[J]. Am J Cardiol,2004,93(6):702-704.
[10] 季柏林. 血浆脑钠素水平与急性冠状动脉综合症病变程度的关系[J]. 浙江医学,2008,30(6):648-649.
[11] 刘树英. 脑利钠肽在ST段抬高型急性心肌梗死溶栓治疗患者的预测价值[J]. World Health Digest,2007,4(9):59-60.
[12] Morita E,Yoshimura M. Increased plasma levels of brain natriuretic peptide in patientswithacute myocardial infarction[J]. Circulation,1993,88:82-91.
[13] 曹雅旻,胡大一,闫丽. 急性冠脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J]. 中华心血管病杂志,2005,10(10):899-902.
[14] Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction[J]. Heart,1999,81:114-120.
(收稿日期:2009-03-05), 百拇医药(纪 军 何胜虎 陈 述 谢 勇 刘晓东 徐日新)